Long telomere length predicts poor clinical outcome in esophageal cancer patients
- 1 February 2017
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 213 (2) , 113-118
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation (81402340)
- Fundamental Research Funds (xjj2014147)
This publication has 37 references indexed in Scilit:
- The incidence and mortality of major cancers in China, 2012Chinese Journal of Cancer, 2016
- Global incidence of oesophageal cancer by histological subtype in 2012Gut, 2014
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- The Role of Telomere Biology in CancerAnnual Review of Pathology: Mechanisms of Disease, 2013
- Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint responseNucleic Acids Research, 2012
- Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisThe Lancet Oncology, 2011
- Guidelines for the management of oesophageal and gastric cancerGut, 2011
- Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancersBritish Journal of Cancer, 2010
- Telomeres: protecting chromosomes against genome instabilityNature Reviews Molecular Cell Biology, 2010
- Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal CancerJournal of Clinical Oncology, 2009